Search the Newsreel

Nephros Inc (NEPH) (Q2 2026) Earnings Call Highlights: Record Revenue and Profitability Surge ...

Nephros Inc (NEPH) reported record quarterly revenue of $6 million in Q2 2026, a 36% year-over-year increase, along with a significant surge in net income (over 400%) and Adjusted EBITDA (260%). The growth was attributed to broad-based improvements across product and service revenues, and …

Earnings call transcript: Nephros posts Q2 2026 growth, shares rise premarket

Nephros reported record revenue growth and stronger profitability in Q2 2026, with shares rising premarket despite a slight revenue miss. The company highlighted a 36% increase in revenue to $6.0 million and a significant rise in service-only revenue, driven by existing customers buying more …

Nephros says its service offerings nearly tripled during Q2

Nephros (Nasdaq: NEPH) reported record second-quarter 2026 net revenue of $6.0 million, a 36% increase year-over-year, with core programmatic revenue growing 27%. The company's service offerings nearly tripled compared to the prior year, reflecting increased customer demand for installation, replacement, and water management support. …

2025 had no U.S. hurricane landfalls—but three Category 5 hurricanes

A report from Neptune Flood highlights that despite 2025 being the first year in a decade without a hurricane landfall in the continental U.S., it still saw three Category 5 hurricanes, emphasizing that the threat lies in storms hitting populated areas rather than just …

Smith & Nephew (LON:SN) Price Target Lowered to GBX 1,290 at JPMorgan Chase & Co.

JPMorgan cuts Smith & Nephew stock rating on market slowdown

JPMorgan downgraded Smith & Nephew PLC to Neutral from Overweight, citing a slowdown in the orthopaedics market and the company's loss of market share in knees and hips. The firm also lowered its price target to GBP12.90 from GBP14.38 and expressed skepticism about the …

JPMorgan cuts Smith & Nephew stock rating on market slowdown By Investing.com

Nephros Q2 2026 Earnings: Revenue Rises 36% as Tariff Refund Lifts Margins

Nephros reported a 36% increase in Q2 2026 net revenue to $6.017 million, with diluted EPS rising to $0.11, significantly boosted by a one-time $0.6 million tariff refund. While the refund inflated profitability, core programmatic revenue still grew 27%, and service-related revenue nearly tripled. …

Smith+Nephew celebrates mobility, recovery and football's greatest traditions during Pro Football Hall of Fame Enshrinement Week

Smith+Nephew, the official Joint Replacement and Sports Medicine Technology Partner of the Pro Football Hall of Fame, is celebrating mobility, recovery, and football traditions during the 2026 Pro Football Hall of Fame Enshrinement Week in Canton, Ohio. The company will host an interactive booth …

Nephros to File Q2 Results After Close, Host 4:30 ET Call

Nephros (Nasdaq: NEPH) announced it will file its second-quarter 2026 financial results after market close on Thursday, August 06, 2026. The company will host a conference call on the same day at 4:30 p.m. ET. Dial-in details for domestic and international participants, along with …

Smith+Nephew Cuts 2026 Outlook Amid Orthopedics Decline

Smith+Nephew has lowered its full-year 2026 revenue guidance from 6% to 4% due to a disappointing Q2, with revenue growing only 1.6% and orthopedics experiencing a decline. Despite this, the company is maintaining its profit guidance by implementing additional efficiency savings from its 12-Point …

Nephros Schedules Second Quarter 2026 Financial Results Conference Call

Nephros, Inc. announced it will file its second quarter financial results on Thursday, August 06, 2026, after market close and will host a conference call on the same day at 4:30 pm ET. The company is a leading water technology provider, offering filtration solutions …

Smith & Nephew Delivers Strong H1 2026 Profit but Cuts Full-Year Revenue Outlook

Higher profit but softer sales at Smith+Nephew (NYSE: SNN)

Smith+Nephew reported higher H1 2026 profits, with trading profit increasing to $566 million and adjusted EPS rising 11.0% to 47.7¢, driven by efficiency savings. However, the company trimmed its full-year revenue growth outlook from around 6% to 4% due to softer sales in Orthopaedics …

REG - Smith & Nephew Plc - Half-Year Report

Smith+Nephew announced its Q2 and H1 2026 results, reporting strong H1 profit growth despite softer revenue growth. The company reaffirmed its full-year guidance for trading profit, free cash flow, and adjusted ROIC, even as it reduced its full-year revenue growth outlook from approximately 6% …

Smith & Nephew plc Provides Earnings Guidance for the Second Half of 2026

Smith & Nephew plc has issued earnings guidance for the second half of 2026, projecting a revenue growth rate between 5.0% and 5.5%. This forecast represents an increase in growth compared to the first half of the year. The announcement was made on August …

Smith & Nephew cuts revenue growth but cost controls pay off

Smith & Nephew SNATS (NYSE:SNN) Announces Quarterly Earnings Results, Misses Estimates By $0.46 EPS

Smith+Nephew (NYSE: SNN) trims 2026 growth to 4% but keeps profit goals

Smith+Nephew has revised its full-year 2026 underlying revenue growth forecast down to around 4% from an earlier estimate of 6%, attributed to softer-than-expected first-half growth and pressures in US Orthopaedics and Advanced Wound Bioactives. Despite this reduction in revenue outlook, the company maintains its …

Smith & Nephew plc Reports Earnings Results for the Half Year Ended June 27, 2026

Why Is Smith & Nephew (LSE:SN) Facing Fresh Market Attention?

Smith & Nephew Lowers Sales Growth Forecast Following Softer Second Quarter

Smith & Nephew has reduced its full-year revenue growth forecast after a weaker-than-expected second quarter, impacted by lower U.S. knee implant sales and changes in wound care reimbursement rules. Despite this, the company maintained its profit growth and free cash flow guidance due to …

Smith & Nephew cuts sales outlook after weak US trading

Smith & Nephew has lowered its full-year revenue growth forecast to approximately 4% due to weaker-than-anticipated performance in its US orthopaedics and wound care businesses during the second quarter. Despite this, the company maintained its guidance for trading profit, free cash flow, and return …

UK Stock Market News: SEGRO, Smith & Nephew, AG Barr

Earnings call transcript: Smith & Nephew Q2 2026 revenue miss weighs on shares

Smith & Nephew (SNN) reported Q2 2026 earnings with underlying revenue growth of 1.6%, below expectations due to softness in U.S. Orthopaedics and Advanced Wound Bioactives. Despite a revised full-year revenue outlook to around 4%, the company maintained its profit and cash flow guidance, …

Smith & Nephew SNATS (NYSE:SNN) Trading Down 5.8% on Disappointing Earnings

Smith & Nephew plc 2026 Q2 - Results - Earnings Call Presentation (NYSE:SNN) 2026-08-04

Smith & Nephew H1 Profit Rises

(RTTNews) - Smith & Nephew Plc (SNN, SN.L) reported that its first half profit before tax totaled $380 million compared to $362 million, a year ago. For the half year ended June 27, 2026, attributable profit was $303 million compared to $293 million in …

Smith & Nephew (NYSE: SNN) details 839.9M voting shares and treasury stock

Smith & Nephew plc has updated its voting share capital as of July 31, 2026, comprising 839,857,161 ordinary shares with voting rights. This figure excludes 37,876,589 treasury shares from its total issued share capital of 877,733,750 shares. Shareholders are instructed to use the voting …

Form 4 Neptune Insurance Holdings Inc For: 31 July By Investing.com

This article announces the filing of Form 4 for Neptune Insurance Holdings Inc. for the period ending July 31st. It provides no further details beyond stating the filing has occurred. The article is part of Investing.com's financial markets coverage.

Nephros Inc (NEPH) Financial Health: Profitability & Balance Sheet Analysis

The article provides an analysis of Nephros Inc's (NEPH) financial health, noting its current financial score of 6.42, ranking 125 out of 159 in its industry. The company's financial status is described as robust, with low operating efficiency, and it recently reported a 6.87% …

Neptune Insurance Holdings Inc. (NP) holder sells 1.63M Class A shares

BSIV Hold 101 LP, a 10% owner of Neptune Insurance Holdings Inc. (NP), sold 1,632,160 Class A shares on July 29, 2026, at $33.22 per share, totaling $54.22 million. This transaction, which was not under a Rule 10b5-1 plan, left BSIV Hold 101 LP …

Bsiv hold 101 sells $54.2m of Neptune Insurance Holdings (NASDAQ:NP) stock

BSIV Hold 101, LP, a 10% owner and director of Neptune Insurance Holdings Inc. (NASDAQ:NP), sold over 1.6 million shares totaling approximately $54.2 million on July 29, 2026. This sale occurred despite Neptune's stock being up nearly 28% over the past year, though InvestingPro …

FTV VII, L.P., director, sells $62 million in Neptune stock

FTV VII, L.P., a director and 10% owner of Neptune Insurance Holdings Inc. (NASDAQ:NP), sold 1,867,840 shares of Class A Common Stock for over $62 million on July 29, 2026. This transaction occurred despite Neptune Insurance Holdings reporting record-breaking Q2 2026 results with strong …

Nano Dimension and 4 More Stocks See Action From Activist Investors

Activists also report to the SEC on Smith & Nephew, Navigator Holdings, Global Net Lease, and Radcom. Continue Reading

Neptune Insurance Holdings (NP) FTV funds sell 1,867,840 shares